Hyderabad Telangana, India

Vinayak Gore

This inventor holds 4 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Mylan Laboratories Limited. Active years: 2014-2017.

USPTO Granted Patents = 4 

% Patents Active = 25.0

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Vinayak Gore: Innovator in Pharmaceutical Patents

Introduction

Vinayak Gore is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent work. With a total of 4 patents to his name, he has established himself as a key figure in the industry.

Latest Patents

Vinayak's latest patents include groundbreaking work on polymorphs of cabozantinib (S)-malate and cabozantinib free base. The present disclosure provides novel crystalline forms of cabozantinib (S)-malate, designated as form-M, M, Mand Mand, as well as novel crystalline forms of cabozantinib free base, form-M, Mand Mand, along with methods of their production. Additionally, he has developed a process for the purification of fluticasone propionate using a ketone solvent and water as an anti-solvent, which relates to an improved process for the preparation of fluticasone propionate.

Career Highlights

Vinayak Gore is currently associated with Mylan Laboratories Limited, where he continues to push the boundaries of pharmaceutical innovation. His work has not only contributed to the advancement of drug formulations but has also enhanced the efficiency of production processes.

Collaborations

Some of his notable coworkers include Ramakoteswara Rao Jetti and Anjaneyaraju Indukuri, who have collaborated with him on various projects, further enriching the innovative environment at Mylan Laboratories Limited.

Conclusion

Vinayak Gore's contributions to pharmaceutical patents exemplify the spirit of innovation in the industry. His work on cabozantinib and fluticasone propionate showcases his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…